Timing of Mobilization on Delirium in Patients After Cardiac Surgery
The Effect of Timing of Mobilization on Delirium in Patients After Cardiac Surgery: a Pilot Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The prevalence of cardiac diseases is high, as the standard treatment for many heart diseases, a bunch of strategies are performed to improve the outcome of cardiac surgery.
Early mobilization is recommended because it is effective in improving symptoms for patients after cardiac surgery. However, the optimal timing of mobilization for postoperative patients is not unclear. How early is early? As early mobilization in the ICU is safe and may reduce healthcare costs, the goal was to assess the effect of early mobilization in the ICU on the incidence and duration of delirium.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jingyuan Xu, M.D.
- Phone Number: 008613851417209
- Email: 13851417209@163.com
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210000
- Recruiting
- Zhongda hospital
-
Contact:
- Jingyuan Xu, M.D.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 1. > 18-year-old postoperative cardiac patient admitted to ICU, the time < 24h
- 2. Patients agree to participate in clinical research and sign informed consent before the start of the study
Exclusion Criteria:
Patients who meet any of the following criteria are not eligible for inclusion in this study:
- 1. Pregnant and lactating women
- 2. There are contraindications to getting out of bed:
- 2.1 Low cardiac output syndrome
- (1) Application of IABP or PCPS (percutaneous cardiopulmonary support)
- (2) High doses of vasoactive drugs (norepinephrine> 0.5ug/kg.min)
- (3) SBP<=80mmHg
- (4) Acrocyanosis, wet and cold
- (5) Metabolic acidosis
- (6) Urine output less than 0.5ml/kg.h for more than 2 hours
- 2.2 Heart rate greater than or equal to 120 beats per minute at rest
- 2.3 Orthostatic hypotension (systolic blood pressure less than 80 mmHg after postural change)
- 2.4 Presence of arrhythmias leading to a drop in blood pressure (e.g., decreased blood pressure due to new-onset atrial fibrillation)
- 2.5 Difficulty breathing at rest or respiratory rate greater than 30 breaths per minute
- 2.6 Postoperative bleeding (200ml in 2-3 hours)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: usual treatment
|
Patients are not allowed to exercise Early Rehabilitation
|
|
Experimental: Early mobilization
early mobilization in the ICU
|
Early Rehabilitation for patients after cardiac surgery
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
duration of delirum
Time Frame: 7 days
|
The duration of delirum in hours
|
7 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
hospital length of stay
Time Frame: hospital length of stay, approximately 10 days
|
hospital length of stay, approximately 10 days
|
hospital length of stay, approximately 10 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Jingyuan Xu, M.D., Study Principal Investigator Southeast University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2023ZDSYLL356-P01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.